News
MLA Malreddy said he is ready to quit if social equations block ministerial posts for Greater Hyderabad and Ranga Reddy, urging fair Cabinet representation ...
In a surprise move, the Congress party has decided to back its rebel candidate Malreddy Ranga Reddy from Ibrahimpatnam Assembly constituency in Ranga Reddy district. TPCC president N. Uttam Kumar ...
Hyderabad: Congress MLA Malreddy Ranga Reddy has called on fellow legislators to invest in the upcoming Future City, emphasising that plots are currently available at affordable rates. Instead of ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech (NASDAQ: ALVO), a ...
Dr. Reddy’s OTC Naproxen Sodium Tablets USP, 220 mg is an over-the-counter nonsteroidal anti-inflammatory drug (NSAID) for use as a pain reliever and fever reducer.
Dr. Reddy’s Laboratories, Inc. USA, an India-based pharmaceutical manufacturer that in 2008 moved to Shreveport after acquiring the former Boots/BASF plant at 8800 Line Avenue, is closing.
Under the terms of the agreement, Dr. Reddy’s acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.
HYDERABAD, India & REYKJAVIK, Iceland, March 18, 2025--Alvotech and Dr. Reddy’s announce FDA acceptance of Biologic License Application for AVT03, a proposed biosimilar to Prolia® and Xgeva®.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results